China Heparin Market Size & Outlook, 2023-2030
China heparin market, 2018-2030 (US$M)
Related Markets
China heparin market highlights
- The China heparin market generated a revenue of USD 355.8 million in 2023 and is expected to reach USD 488.7 million by 2030.
- The China market is expected to grow at a CAGR of 4.6% from 2024 to 2030.
- In terms of segment, porcine was the largest revenue generating source in 2023.
- Bovine is the most lucrative source segment registering the fastest growth during the forecast period.
Heparin market data book summary
| Market revenue in 2023 | USD 355.8 million |
| Market revenue in 2030 | USD 488.7 million |
| Growth rate | 4.6% (CAGR from 2023 to 2030) |
| Largest segment | Porcine |
| Fastest growing segment | Bovine |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Porcine, Bovine |
| Key market players worldwide | Pfizer Inc, Sanofi SA, Aspen Pharmacare Holdings Ltd, Fresenius SE & Co KGaA, Novartis AG ADR, GSK PLC ADR, Dr. Reddy’s Laboratories, LEO Pharma, B. Braun Medical |
Other key industry trends
- In terms of revenue, China accounted for 4.8% of the global heparin market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan heparin market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 357.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Heparin Market Scope
Heparin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China heparin market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to heparin market will help companies and investors design strategic landscapes.
Porcine was the largest segment with a revenue share of 89.18% in 2023. Horizon Databook has segmented the China heparin market based on porcine, bovine covering the revenue growth of each sub-segment from 2018 to 2030.
The market in China is expected to witness a lucrative CAGR over the forecast years. China supplies nearly 80% of heparin raw materials globally. However, the COVID-19 pandemic has impacted the supply chain negatively.
Furthermore, the recent outbreak of African swine flu has led to significant losses in China’s swine population, diminishing production of raw materials and exports of heparin and related products. However, exports are steadily regaining strength.
In June 2020, exports were at 11,486 kg, which increased by over 100% in July, to reach 24,274 kg. Over the recent past, China has typically produced nearly 30 trillion international units of heparin per year.
Reasons to subscribe to China heparin market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China heparin market databook
-
Our clientele includes a mix of heparin market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China heparin market , including forecasts for subscribers. This country databook contains high-level insights into China heparin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China heparin market size, by source, 2018-2030 (US$M)
China Heparin Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
